Approval · Notice of Compliance 9239 · 2007
BANAMINE: Notice of Compliance 9239
Issued December 12, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9239
- Date
- December 12, 2007
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate source of active ingredient
- Therapeutic class
- Anti-inflammatory, analgesic, antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BANAMINE | 00465305 | Marketed |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML